Fulgent Genetics (FLGT) Assets Average (2016 - 2026)

Fulgent Genetics has disclosed Assets Average across 11 years of filings, most recently posting $1.1 billion for Q2 2026.

• In Q2 2026, Assets Average fell 6.65% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (down 6.65% YoY), while the FY2025 annual figure was $1.2 billion, down 0.89% from the prior year.
• Assets Average came in at $1.1 billion for Q2 2026 at Fulgent Genetics, down from $1.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.5 billion in Q2 2022 to a low of $1.1 billion in Q2 2026.
• Average Assets Average over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2024.
• Year-over-year, Assets Average surged 61.47% in 2022 and declined 10.77% in 2024.
• Over 5 years, Assets Average stood at $1.4 billion in 2022, then fell by 7.1% to $1.3 billion in 2023, then retreated by 5.4% to $1.2 billion in 2024, then fell by 1.04% to $1.2 billion in 2025, then decreased by 7.52% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $1.1 billion in Q2 2026, $1.2 billion in Q1 2026, and $1.2 billion in Q4 2025.